Can a generalizable dose-effect relationship be inferred for cannabidiol? Evidence from the preclinical literature

Abstract Rationale Cannabidiol (CBD) modulates anxiety and fear in rodents; however, the dose-dependent characteristics of these effects remain unclear. Objectives & Methods Regression-based analyses assessed how consistent dose-effect inferences are across diverse studies and determined whether linear or nonlinear models best describe the relationship between CBD dose and behavioral outcomes. Hedges’ g effect sizes from 312 experiments in mice and rats were analyzed separately and in pooled datasets, using both raw and allometrically normalized doses. We also evaluated how biological and procedural variables moderated dose-effect relationships. Results Intermediate doses of systemic CBD administration were more often associated with larger antiaversive effect sizes; however, this trend did not hold across species or behavioral domains. Some analyses showed nonlinear trends, primarily associated with high-dose observations. After allometric scaling and pooling of anxiety and conditioned fear datasets, linear models fit better than nonlinear models. Analyses of pooled and anxiety datasets revealed no significant moderators of the dose-effect relationship. In contrast, analyses limited to conditioned fear identified species as a significant moderator, while sex, stress history, treatment regimen, age, and treatment-testing interval were not significant. Conclusions These findings indicate that the preclinical literature does not support a stable or generalizable CBD dose-effect function. The observed relationships likely reflect substantial methodological heterogeneity and may also reflect CBD’s pharmacological complexity. Factorial studies with balanced dose distributions and controlled experimental conditions are necessary to improve reproducibility and mechanistic understanding of CBD’s antiversive effects.

Authors

Institutions

Publication Details

Journal
Psychopharmacology
Published
2026-11-14
DOI
https://doi.org/10.1007/s00213-026-07218-1
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Can a generalizable dose-effect relationship be inferred for cannabidiol? Evidence from the preclinical literature

Isabel Werle, Leandro Jose Bertoglio, Francisco Silveira Guimarães, Maria E. G. Lewandowski et al.
Psychopharmacology
Cannabis and Cannabinoid Research
article

Can a generalizable dose-effect relationship be inferred for cannabidiol? Evidence from the preclinical literature

Isabel Werle, Leandro Jose Bertoglio, Francisco Silveira Guimarães, Maria E. G. Lewandowski, Maria E. C. Probst
article en

Abstract

Abstract Rationale Cannabidiol (CBD) modulates anxiety and fear in rodents; however, the dose-dependent characteristics of these effects remain unclear. Objectives & Methods Regression-based analyses assessed how consistent dose-effect inferences are across diverse studies and determined whether linear or nonlinear models best describe the relationship between CBD dose and behavioral outcomes. Hedges’ g effect sizes from 312 experiments in mice and rats were analyzed separately and in pooled datasets, using both raw and allometrically normalized doses. We also evaluated how biological and procedural variables moderated dose-effect relationships. Results Intermediate doses of systemic CBD administration were more often associated with larger antiaversive effect sizes; however, this trend did not hold across species or behavioral domains. Some analyses showed nonlinear trends, primarily associated with high-dose observations. After allometric scaling and pooling of anxiety and conditioned fear datasets, linear models fit better than nonlinear models. Analyses of pooled and anxiety datasets revealed no significant moderators of the dose-effect relationship. In contrast, analyses limited to conditioned fear identified species as a significant moderator, while sex, stress history, treatment regimen, age, and treatment-testing interval were not significant. Conclusions These findings indicate that the preclinical literature does not support a stable or generalizable CBD dose-effect function. The observed relationships likely reflect substantial methodological heterogeneity and may also reflect CBD’s pharmacological complexity. Factorial studies with balanced dose distributions and controlled experimental conditions are necessary to improve reproducibility and mechanistic understanding of CBD’s antiversive effects.

Psychopharmacology
Universidade de São Paulo (BR), Universidade Federal de Santa Catarina (BR)
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon